Shanghai Pharmaceuticals (02607) Announces Interim Dividend for First Half of 2025

Bulletin Express10-30

Shanghai Pharmaceuticals Holding Co., Ltd. (Stock code: 02607) announced an interim ordinary dividend of RMB 1.2 per 10 shares for the six months ended 30 June 2025. The date of shareholder approval, ex-dividend date, record date, payment date, default currency, and exchange rate are all to be announced.

The share registrar for the dividend is Tricor Investor Services Limited, located at 17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong. Details regarding any withholding tax to be applied to the dividend are also pending announcement.

As indicated, the executive Directors of Shanghai Pharmaceuticals Holding Co., Ltd. are Mr. YANG Qiuhua, Mr. SHEN Bo, Mr. LI Yongzhong, and Mr. DONG Ming. The non-executive Director is Mr. ZHANG Wenxue, and the independent non-executive Directors are Mr. GU Zhaoyang, Mr. Manson FOK, Mr. WANG Zhong, and Ms. MAN Kwan.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment